TCF19 is a transcription factor that plays critical roles in cell cycle regulation, metabolic homeostasis, and disease pathogenesis. As a transcription factor, TCF19 regulates gene expression by binding to promoter regions and forming complexes with other regulatory proteins 12. In cell cycle control, TCF19 functions as a central regulator of proliferation-related genes and is essential for the G1/S transition, with its downregulation leading to cell cycle arrest 3. TCF19 demonstrates significant involvement in metabolic regulation, particularly in glucose homeostasis and lipid metabolism. It interacts with p53 to co-regulate metabolic genes including TIGAR and SCO2, which control glycolysis and oxidative phosphorylation respectively 2. Additionally, TCF19 associates with TCF7l2 to regulate fatty acid chain elongase HACD3 under lipid-induced stress conditions 4. The protein shows important disease relevance across multiple pathologies. In cancer, TCF19 promotes tumor progression through various mechanisms: facilitating epithelial-mesenchymal transition in breast cancer via the TCF19/miR-199a-5p/SP1/LOXL2 pathway 5, and regulating glycolysis and macrophage M2 polarization in osteosarcoma through CDKN2A upregulation 1. TCF19 is also implicated in cardiovascular disease, where its downregulation contributes to endothelial cell dysfunction during heart failure progression 3, and in intervertebral disc degeneration, where it plays a pivotal role in disease progression 6.